Welcoming low testosterone as a cardiovascular risk factor

被引：56

作者：

Maggio, M. ^{[2
]}

Basaria, S. ^{[1
]}

机构：

[1] Boston Univ, Androgen Clin Res Unit, Div Endocrinol & Metab, Sch Med,Boston Med Ctr,Dept Internal Med, Boston, MA 02118 USA

[2] Univ Parma, Dept Internal Med, Div Endocrinol & Metab, I-43100 Parma, Italy

来源：

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | 2009年 / 21卷 / 04期

关键词：

hypogonadism; metabolic syndrome; diabetes; inflammation; ENDOTHELIAL PROGENITOR CELLS; ANDROGEN DEPRIVATION THERAPY; HORMONE-BINDING GLOBULIN; CORONARY-ARTERY-DISEASE; LOW SERUM TESTOSTERONE; ENDOGENOUS TESTOSTERONE; INSULIN-RESISTANCE; METABOLIC SYNDROME; BODY-COMPOSITION; SEX-HORMONES;

D O I：

10.1038/ijir.2009.25

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Male hypogonadism now has a new spectrum of complications. They are mainly cardiometabolic in nature. Low serum testosterone levels are a risk factor for diabetes, metabolic syndrome, inflammation and dyslipidemia. These metabolic and inflammatory complications are not without consequences. Recent studies have shown low serum testosterone levels to be an independent risk factor of cardiovascular and all-cause mortality. It is time to welcome low serum testosterone levels as a cardiovascular risk factor. International Journal of Impotence Research (2009) 21, 261-264; doi: 10.1038/ijir.2009.25; published online 18 June 2009

引用

页码：261 / 264

页数：4

共 34 条

[21]

Malkin CJ, 2009, FRONT HORM RES, V37, P183, DOI 10.1159/000176053

[22] The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men [J].